Cart
sales@molnova.com
Tafetinib
CAS No. 1032265-57-8
Tafetinib( —— )
Catalog No. M34438 CAS No. 1032265-57-8
Tafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 592 | In Stock |
|
| 10MG | 843 | In Stock |
|
| 25MG | 1264 | In Stock |
|
| 50MG | 1655 | In Stock |
|
| 100MG | 2260 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 4538 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTafetinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionTafetinib (SIM-010603) is a novel potent and orally available tyrosine kinase inhibitor with anti-angiogenic and anti-tumour activity.
-
DescriptionTafetinib (SIM010603) is an oral multi-targets receptor tyrosine kinases inhibitor. Tafetinib inhibitsstem cell factor receptor (Kit),vascular endothelial growth factor receptor-2 (VEGFR-2),platelet-derived growth factor receptor-β (PDGFR-β),glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET), andFms-like tyrosine kinase-3 (FLT3)withIC50values between 5.0 and 68.1 nmol/l. Tafetinib inhibits the phosphorylation ofPDGFR-βandVEGFR-2. Tafetinib inhibits endothelial cell proliferation, endothelial cells chemotaxis, and corneal angiogenesis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetTyrosinase
-
RecptorTyrosine Kinases
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1032265-57-8
-
Formula Weight424.51
-
Molecular FormulaC24H29FN4O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1/C(=C/2\C3=C(C(C(NCCN(CC)CC)=O)=C(C)N3)CCC2)/C=4C(N1)=CC=C(F)C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wang D, et al. Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor. Cancer Chemother Pharmacol. 2012;69(1):173-183.?
molnova catalog
related products
-
KN-93
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent kinase II (CaMKII), competitively blocking CaM binding to the kinase.
-
2-(4-(4-methoxybenzy...
Detail unknown.
-
SU 5616
SU 5616 (WAY-608241) regulates abnormal cell proliferation and modulates tyrosine kinase signaling.
